#1 Clinical Trials Search in Europe

Clarithromycin

Clarithromycin is an antibiotic medication that has been the subject of numerous clinical trials to evaluate its effectiveness in treating various conditions. This article explores the use of clarithromycin in clinical studies, focusing on its applications in treating infections, its bioavailability, and its potential anti-inflammatory properties. We’ll examine how researchers are investigating this drug to improve patient outcomes and expand our understanding of its therapeutic potential.

Table of Contents

What is Clarithromycin?

Clarithromycin is an antibiotic medication that belongs to the macrolide class of drugs. It is also known by the brand names Biaxin® and Klaricid[1][2]. This medication is widely used to treat various bacterial infections and has been the subject of numerous clinical trials to explore its potential benefits in different medical conditions.

Uses of Clarithromycin

Clarithromycin is prescribed for several medical conditions, including:

  • Respiratory tract infections: It is commonly used to treat infections of the lungs and airways, such as community-acquired pneumonia (CAP)[3].
  • Helicobacter pylori infection: Clarithromycin is part of combination therapies used to eradicate H. pylori, a bacterium that can cause stomach ulcers and other digestive issues[4].
  • Skin and soft tissue infections: It can be effective against certain skin bacterial infections.
  • COVID-19: Recent studies have explored its potential anti-inflammatory effects in treating COVID-19[5].
  • Lymphoma: Some clinical trials have investigated its use in certain types of lymphoma, such as mucosa-associated lymphoid tissue (MALT) lymphoma[6].

How Clarithromycin Works

Clarithromycin works in two main ways:

  1. Antibiotic action: It interferes with the protein synthesis of bacteria, preventing them from growing and multiplying. This helps the body’s immune system to fight off the infection more effectively[7].
  2. Anti-inflammatory effects: Recent research has shown that clarithromycin also has anti-inflammatory properties. This means it can help reduce inflammation in the body, which may be beneficial in conditions like COVID-19 where excessive inflammation is a concern[5].

Dosage Forms and Administration

Clarithromycin is available in several forms:

  • Oral tablets: These come in 250mg and 500mg strengths[1][8].
  • Extended-release tablets: These are designed to release the medication slowly over time.
  • Oral suspension: A liquid form that can be easier for some patients to take, especially children.

The typical dosage for adults is 250mg or 500mg twice daily, but this can vary depending on the condition being treated and the patient’s individual factors. Always follow your healthcare provider’s instructions regarding dosage and duration of treatment[5].

Clinical Trials and Research

Clarithromycin has been the subject of numerous clinical trials exploring its efficacy in various conditions:

  • COVID-19: The ACHIEVE trial investigated the use of clarithromycin in early COVID-19 treatment, focusing on its potential to reduce inflammation and prevent severe respiratory failure[5].
  • Lymphoma: Studies have explored its use in combination with other medications for treating certain types of lymphoma[6][7].
  • H. pylori eradication: Trials have compared different treatment regimens including clarithromycin for effectively eliminating H. pylori infections[4][2].
  • Community-acquired pneumonia: Research has investigated the benefits of adding clarithromycin to standard treatments for pneumonia[3].

Potential Side Effects

Like all medications, clarithromycin can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Stomach pain
  • Headache
  • Changes in taste

More serious side effects are rare but can occur. These may include severe diarrhea, liver problems, or allergic reactions. Always inform your healthcare provider if you experience any unusual symptoms while taking clarithromycin.

Precautions and Interactions

Clarithromycin can interact with other medications, so it’s important to inform your healthcare provider about all medications, supplements, and herbal products you’re taking. Some key points to remember:

  • It may not be suitable for people with certain heart conditions or liver problems.
  • It can interact with drugs like statins (cholesterol-lowering medications) and increase the risk of side effects.
  • Pregnant women and those breastfeeding should consult their doctor before using clarithromycin.
  • It may affect the effectiveness of birth control pills.

Always follow your healthcare provider’s instructions and report any concerns or side effects promptly.

Aspect Details
Primary Uses Treatment of H. pylori infections, potential anti-inflammatory effects
Common Dosages 250 mg or 500 mg tablets, typically twice daily
Administration Methods Oral tablets, intraluminal application during endoscopy
Combination Therapies With amoxicillin and PPIs, in quadruple therapy regimens
Unique Applications COVID-19 treatment, potential use in lymphoma
Effectiveness Measures H. pylori eradication rates, symptom improvement, bioavailability studies
Safety Considerations Potential drug interactions, cardiotoxicity when combined with certain medications

FAQ

  • What is clarithromycin primarily used for in clinical trials? Clarithromycin is primarily studied for its effectiveness in treating Helicobacter pylori infections, which are associated with gastritis, peptic ulcers, and gastric cancer. It's also being investigated for its potential anti-inflammatory properties in conditions like COVID-19.
  • How is clarithromycin administered in clinical trials? In clinical trials, clarithromycin is typically administered orally in tablet form. Dosages vary but commonly include 250 mg or 500 mg tablets taken twice daily. Some studies also explore intraluminal administration during endoscopic procedures.
  • What are some of the combination therapies involving clarithromycin? Clarithromycin is often studied in combination with other medications. Common combinations include clarithromycin with amoxicillin and a proton pump inhibitor for H. pylori treatment, or with other antibiotics like metronidazole in quadruple therapy regimens.
  • Are there any unique applications of clarithromycin being studied? Yes, some unique applications being studied include the use of clarithromycin for its anti-inflammatory properties in COVID-19 patients and its potential effectiveness in treating certain types of lymphoma.
  • How do researchers measure the effectiveness of clarithromycin in clinical trials? Researchers measure clarithromycin's effectiveness through various methods, including eradication rates of H. pylori, changes in clinical symptoms, bioavailability studies comparing different formulations, and in some cases, by measuring changes in inflammatory markers or viral loads.

Ongoing Clinical Trials on Clarithromycin

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Greece

  • Study on Antibiotic Combination of Ceftriaxone, Clarithromycin, and Metronidazole for Pregnant Women with Threatened Miscarriage and Intact Membranes

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Helicobacter pylori (H. pylori): A type of bacteria that can infect the stomach and is a common cause of peptic ulcers and gastritis. It's a major focus of clarithromycin treatment in many clinical trials.
  • Bioavailability: The extent and rate at which a drug enters the body's circulation to produce an active effect. Many trials compare the bioavailability of different clarithromycin formulations.
  • Eradication rate: The percentage of patients in whom a particular infection, often H. pylori in clarithromycin trials, is successfully eliminated after treatment.
  • Proton pump inhibitor (PPI): A class of drugs that reduce stomach acid production, often used in combination with clarithromycin for H. pylori treatment.
  • Quadruple therapy: A treatment regimen that includes four different medications, often including clarithromycin, used to treat H. pylori infections.
  • Intraluminal therapy: A method of administering medication directly into the lumen (inner space) of an organ, such as the stomach during an endoscopic procedure.
  • Anti-inflammatory: A property of certain substances, including some antibiotics like clarithromycin, that helps reduce inflammation in the body.
  • Cytokine: Small proteins released by cells that have specific effects on the interactions and communications between cells, often involved in inflammatory responses.

References

  1. https://clinicaltrials.gov/study/NCT00648830
  2. https://clinicaltrials.gov/study/NCT03516669
  3. https://clinicaltrials.gov/study/NCT06294600
  4. https://clinicaltrials.gov/study/NCT02646332
  5. https://clinicaltrials.gov/study/NCT04398004
  6. https://clinicaltrials.gov/study/NCT03031483
  7. https://clinicaltrials.gov/study/NCT00461084
  8. https://clinicaltrials.gov/study/NCT00648960